Hiroshi Nagase, Toru Nemoto, Ayaka Matsubara, Manabu Saito, Naoshi Yamamoto, Yumiko Osa, Shigeto Hirayama, Mayumi Nakajima, Kaoru Nakao, Hidenori Mochizuki, Hideaki Fujii
Index: Bioorg. Med. Chem. Lett. 20(21) , 6302-5, (2010)
Full Text: HTML
We have reported previously the novel δ-opioid agonist, SN-28, which was more potent in in vitro assays than the prototype δ-agonists, TAN-67 and SNC-80. However, when administered by subcutaneous injection, this compound showed no analgesic effect at dosages greater than 30mg/kg in the acetic acid writhing test. We speculated that SN-28 was not effective in the test because the presence of the charged ammonium groups prevented its penetration through the blood-brain barrier. On the basis of our proposal, we designed the novel δ-agonist, KNT-127, which was effective with systemic administration.Copyright © 2010 Elsevier Ltd. All rights reserved.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
SNC80
CAS:156727-74-1 |
C28H39N3O2 |
PKA and ERK1/2 are involved in dopamine D₁ receptor-induced ...
2013-06-21 [Life Sci. 92(23) , 1101-9, (2013)] |
Novel screening assay for the selective detection of G-prote...
2013-01-01 [J. Pharmacol. Exp. Ther. 344(1) , 179-88, (2013)] |
Dual efficacy of delta opioid receptor-selective ligands for...
2010-10-01 [J. Pharmacol. Exp. Ther. 335(1) , 133-9, (2010)] |
Cholecystokinin receptors mediate tolerance to the analgesic...
2010-01-01 [Pain 148(1) , 84-93, (2010)] |
Effects of the delta-opioid agonist SNC80 on the abuse liabi...
2011-08-01 [Psychopharmacology 216(3) , 431-9, (2011)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved